Company news
MannKind Corporation news in 2022
MannKind Corporation's news releases, calls and decks from 2022, newest first.
MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting
November 9, 2022
MannKind Corporation Reports 2022 Third Quarter Financial Results
November 7, 2022
MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022
October 31, 2022
MannKind Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference
September 20, 2022
Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine
September 5, 2022
MannKind Corporation to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
August 31, 2022
MannKind Corporation Reports 2022 Second Quarter Financial Results
August 8, 2022
MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022
August 1, 2022
MannKind Corporation to Participate in the BTIG Biotechnology Conference
July 31, 2022
Mannkind to Host Product Theater and Booth at the American Diabetes Association’s 82nd Scientific Sessions in New Orleans, June 3-7
June 2, 2022
MannKind’s Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™
May 23, 2022
MannKind Corporation to Ring the Nasdaq Stock Market Opening Bell
May 18, 2022
MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand Pharma
May 16, 2022
MannKind Corporation Participating at Upcoming Conferences
May 8, 2022
MannKind Corporation Reports 2022 First Quarter Financial Results
May 4, 2022
MannKind Corporation to Hold 2022 First Quarter Financial Results Conference Call on May 5, 2022
April 27, 2022
MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30
April 26, 2022
MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference
March 27, 2022
MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease Summit
March 21, 2022
MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare Conference
March 7, 2022
Update on Tyvaso DPI™ New Drug Application
February 23, 2022
MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial Results
February 23, 2022
MannKind Corporation to Hold 2021 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2022
February 20, 2022
MannKind Corporation to Participate in SVB Leerink 2022 Global Healthcare Conference
February 9, 2022
MannKind Extends Collaboration With Thirona Bio on Fibrotic Lung Diseases
January 4, 2022
MannKind Corporation to Participate in H.C. Wainwright Bioconnect Conference
January 4, 2022